ACC 2023 – the market tries to take Medtronic’s pulse

Medtronic is on track to have the first pulsed field ablation catheter approved in the US, after this week’s success in the pivotal trial of its PulseSelect device. Expectations are enormous for pulsed field technology, with some believing that it could completely replace the more dangerous ablation techniques in current use. But Medtronic’s stock closed down 2%.